Autologous lak cells interleukin 2 patents

Treatment of tumors with autologous LAK cells, interleukin-2 and an ...

Filed: December 5th, 1989 [Granted]

Patent Number: 5002879

The use of autologous LAK cells and interleukin-2 to treat neoplastic disease states is known. See SA Rosenberg et al., New England Journal of Medicine, ...

METHOD OF PROLIFERATING LAK CELL

Filed: August 1st, 2007 [Pending]

Patent Application Number: 12375663

For example, by culturing a cell suspension containing the autologous lymphocytes in a ... 4 is a graph showing an effect of differences of interleukin-2 ...

Process of enriching adherent CD4.sub.+ T cells from monocyte depleted ...

Filed: January 31st, 1991 [Granted]

Assignee: Terumo Corporation

Patent Number: 5374549

WITH INTERLEUKIN 2 AND INTERLEUKIN 4 5 141: 2349; te Velde et al. ... on B tration of autologous LAK cells to patients with ad- cenS; x cells, NK cells, ...

Composition and method of cancer antigen immunotherapy

Filed: July 5th, 2001 [Pending]

Patent Application Number: 9899780

See Cher & Mosmann, Two Types of Murine Helper T Cell Clone. II. ... After culturing the cells in high concentrations of IL-2, the LAK cells were then ...

AUTOLOGOUS IMMUNE CELL THERAPY: CELL COMPOSITIONS, METHODS AND APPLICATIONS ...

Filed: July 31st, 1998 [Pending]

Patent Application Number: 9127411

In particular, methods of autologous cell therapy are provided. ... toxicities associated with the infusion of the interleukin-2 (IL-2) with the cells.

Detection, localization and staging of tumors using labeled activated ...

Filed: October 10th, 2003 [Pending]

Patent Application Number: 10530736

The cells can be proliferated in the presence of interleukin-2, ... killer (LAK) cells] or sensitized against autologous tumor cells by in vitro co-culture ...

Lysine-glycosylated recombinant interleukin-2

Filed: June 1st, 1990 [Granted]

Assignee: E I Du Pont de Nemours and Company

Patent Number: 5312903

Interleukin-2 (IL-2) is a protein secreted by lymphocytes which belongs to ... by administration of recombinant IL-2 (rIL-2) and autologous LAK cells has ...

Process for preparing lymphokine activated killer cells

Filed: April 20th, 1987 [Granted]

Assignee: E I Du Pont de Nemours and Company

Patent Number: 4849329

The authors disclose that LAK cells kill fresh autologous and allogeneic human ... They report that pure, recombinant interleukin-2 generates LAK cells ...